VELCADE in MALT Lymphoma Pretreated With Prior Systemic Therapy

Update Il y a 4 ans
Reference: NCT00210327

Woman and Man

Extract

The primary objective of this study is to assess the antitumor activity (in terms of overall response rate - ORR - i.e. sum of complete and partial responses)of bortezomib in pretreated MALT lymphomas with one prior sistemic therapy regimen


Inclusion criteria

  • Lymphoma, Mucosa-Associated Lymphoid Tissue

Links